Key Dates

Related Announcements

RFA-CA-22-051 - Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on November 2, 2022, from 11:00 AM to 12:00 PM Eastern Time for the Funding Opportunity Announcement (FOA) RFA-CA-22-051, Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required).

NCI staff will assist potential applicants by explaining the goals and objectives of the new HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network and answering questions from attendees about this FOA.

Prospective applicants are encouraged to submit their questions in advance of the webinar via email cascade@mail.nih.gov or ask questions during the webinar. The webinar will be recorded. The webinar recording and frequently asked questions (FAQs) and corresponding answers will be posted to the NCI's HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network website following the webinar.

Webinar Information:

To join the Webinar, pre-registration is required through ZoomGov at https://nih.zoomgov.com/meeting/register/vJIscO2qrDovHR_nOOGdp7tulA8eX8lACAk

Specific webinar information including the webinar link will be provided upon registration.

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-22-051.

Inquiries

Please direct all inquiries to:

Vikrant V. Sahasrabuddhe, M.B.B.S., Dr.P.H.
National Cancer Institute (NCI)
Telephone: 240-276-7332
Email: sahasrabuddhevv@mail.nih.gov; cascade@mail.nih.gov